Over the 90-day window ending February 07, 2026, Xeris Biopharma Holdings's three dominant insider ownership positions are held by Director Paul R Edick (3.80Mn shares), Director John Patrick Jr Shannon (2.94Mn shares), Officer Kevin Mcculloch (1.73Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Paul R Edick | Nan | 3,801,494 | 31 Jan, 2024 |
| John Patrick Jr Shannon | Nan | 2,935,578 | 02 Feb, 2026 |
| Kevin Mcculloch | Nan | 1,727,827 | 02 Feb, 2026 |
| Steven Pieper | Nan | 1,367,013 | 02 Feb, 2026 |
| Beth Hecht | Nan | 1,243,174 | 02 Feb, 2026 |
| Steven Prestrelski | Chief Scientific Officer | 719,780 | 01 Feb, 2023 |
| John Johnson | 698,083 | 19 Dec, 2025 | |
| Anh Tu Nguyen | Nan | 424,323 | 02 Feb, 2026 |
| Kenneth Erland Johnson | Nan | 320,446 | 03 Feb, 2025 |
| Jeffrey W Sherman | 219,188 | 29 Aug, 2025 | |
| Garheng Kong | 214,144 | 04 Jun, 2025 | |
| Barbara-Jean Anne Bormann-Kennedy | 142,500 | 15 Dec, 2025 | |
| Marla Persky | 142,000 | 12 Sep, 2025 | |
| John P. Schmid | 138,359 | 05 Jun, 2024 | |
| Ricki Louise Fairley | 135,000 | 05 Jun, 2024 | |
| Dawn Halkuff | 115,000 | 13 Aug, 2025 | |
| James Aloysius Brady | 100,000 | 28 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Beth Hecht | Common Stock | D | 16,667 | $7.45 | 1,243,174 | D | S |
| 31 Jan, 2026 | John Patrick Jr Shannon | Common Stock | D | 111,621 | $7.36 | 3,046,328 | D | F |
| 31 Jan, 2026 | John Patrick Jr Shannon | Common Stock | D | 110,750 | $7.36 | 2,935,578 | D | F |
| 31 Jan, 2026 | John Patrick Jr Shannon | Common Stock | D | 118,134 | $7.36 | 3,157,949 | D | F |
| 31 Jan, 2026 | Beth Hecht | Common Stock | D | 24,266 | $7.36 | 1,259,841 | D | F |
| 31 Jan, 2026 | Beth Hecht | Common Stock | D | 46,914 | $7.36 | 1,284,107 | D | F |
| 31 Jan, 2026 | Beth Hecht | Common Stock | D | 98,375 | $7.36 | 1,331,021 | D | F |
| 31 Jan, 2026 | Steven Pieper | Common Stock | D | 27,319 | $7.36 | 1,367,013 | D | F |
| 31 Jan, 2026 | Steven Pieper | Common Stock | D | 111,765 | $7.36 | 1,460,782 | D | F |
| 31 Jan, 2026 | Steven Pieper | Common Stock | D | 66,450 | $7.36 | 1,394,332 | D | F |
| 31 Jan, 2026 | Kevin Mcculloch | Common Stock | D | 30,289 | $7.36 | 1,755,146 | D | F |
| 31 Jan, 2026 | Kevin Mcculloch | Common Stock | D | 68,454 | $7.36 | 1,785,435 | D | F |
| 31 Jan, 2026 | Kevin Mcculloch | Common Stock | D | 27,319 | $7.36 | 1,727,827 | D | F |
| 30 Jan, 2026 | John Patrick Jr Shannon | Common Stock | A | 478,436 | $0.00 | 3,276,083 | D | A |
| 30 Jan, 2026 | Beth Hecht | Common Stock | A | 121,293 | $0.00 | 1,429,396 | D | A |
| 30 Jan, 2026 | Steven Pieper | Common Stock | A | 154,986 | $0.00 | 1,572,547 | D | A |
| 30 Jan, 2026 | Kevin Mcculloch | Common Stock | A | 168,463 | $0.00 | 1,853,889 | D | A |
| 30 Jan, 2026 | Anh Tu Nguyen | Common Stock | A | 121,293 | $0.00 | 424,323 | D | A |
| 08 Jan, 2026 | Kevin Mcculloch | Common Stock | D | 15,000 | $8.00 | 1,685,426 | D | S |
| 05 Jan, 2026 | John Patrick Jr Shannon | Common Stock | A | 64,265 | $1.55 | 2,769,611 | D | M |